TerrAscend (TSNDF) Liabilities from Discontinued Operations (2021 - 2026)
TerrAscend (TSNDF) posted quarterly Liabilities from Discontinued Operations of 6881000.0 for Q1 2026, down 45.46% quarter-over-quarter from 12616000.0 in Q4 2025.
TerrAscend (TSNDF) Liabilities from Discontinued Operations (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has reported Liabilities from Discontinued Operations for 6 consecutive years, with 6881000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Liabilities from Discontinued Operations changed N/A year-over-year to 6881000.0; the TTM figure through Mar 2026 stood at 6881000.0 (changed N/A YoY), while the FY2025 annual figure was 12616000.0, down 48.08% from the prior year.
- Liabilities from Discontinued Operations declined to 6881000.0 in Q1 2026 per TSNDF's latest filing, from 12616000.0 in the prior quarter.
- Across five years, Liabilities from Discontinued Operations topped out at 24298000.0 in Q4 2024 and bottomed at 1124000.0 in Q3 2023.
- Historically, Liabilities from Discontinued Operations has averaged 11312333.33 across 5 years, with a median of 9111000.0 in 2022.
- Annual changes were most pronounced in 2022 — Liabilities from Discontinued Operations climbed 12.87% — and 2025, when it slumped 48.08%.
- TerrAscend's Liabilities from Discontinued Operations stood at 9111000.0 in 2022, then tumbled by 87.66% to 1124000.0 in 2023, then surged by 2061.74% to 24298000.0 in 2024, then sank by 48.08% to 12616000.0 in 2025, then plunged by 45.46% to 6881000.0 in 2026.
- Business Quant data shows TSNDF's Liabilities from Discontinued Operations at 6881000.0 in Q1 2026, 12616000.0 in Q4 2025, and 14856000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | TerrAscend | 197.99 Mn | 155.88 Mn | 36.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.88 Mn |
| Mar 31, 2026 | 6.88 Mn |
| Dec 31, 2025 | 12.62 Mn |
| Dec 31, 2025 | 12.62 Mn |
| Sep 30, 2025 | 14.86 Mn |
| Sep 30, 2025 | 14.86 Mn |
| Jun 30, 2025 | 23.99 Mn |
| Jun 30, 2025 | 23.99 Mn |
| Dec 31, 2024 | 24.30 Mn |
| Dec 31, 2024 | 24.30 Mn |
| Sep 30, 2023 | 1.12 Mn |
| Sep 30, 2023 | 1.12 Mn |
| Jun 30, 2023 | 1.47 Mn |
| Jun 30, 2023 | 1.47 Mn |
| Mar 31, 2023 | 7.47 Mn |
| Mar 31, 2023 | 7.47 Mn |
| Dec 31, 2022 | 9.11 Mn |
| Dec 31, 2022 | 9.11 Mn |
| Dec 31, 2021 | 8.07 Mn |
| Dec 31, 2021 | 8.07 Mn |